Back to CytomX Therapeutics, Inc.

CytomX Therapeutics, Inc.

All insider transactions

9 transactions

DateMoveSecurityInsiderΔ sharesPriceValueHeld afterImpact
Mar 17, 2026SellCommon StockMcCarthy Sean A.
CEO
-118,969$6.42$764.1K1,078,922medium
Mar 17, 2026SellCommon StockChu Yu-Waye
Executive
-21,279$6.42$136.7K189,446medium
Mar 17, 2026SellCommon StockBELVIN MARCIA
Executive
-31,492$6.42$202.3K300,760medium
Mar 17, 2026SellCommon StockOgden Christopher
Executive
-19,323$6.42$124.1K296,948medium
Feb 2, 2026Other
Grant / award
Common StockMcCarthy Sean A.
CEO
+210,000$0.00$01,197,891low
Feb 2, 2026Other
Grant / award
Common StockLester Rachael
Executive
+20,000$0.00$020,000low
Feb 2, 2026Other
Grant / award
Common StockChu Yu-Waye
Executive
+75,000$0.00$0210,725low
Feb 2, 2026Other
Grant / award
Common StockBELVIN MARCIA
Executive
+60,000$0.00$0332,252low
Feb 2, 2026Other
Grant / award
Common StockOgden Christopher
Executive
+90,000$0.00$0316,271low
← PrevPage 1 of 1Next →